Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.87 | 15.93 |
| PEG Ratio (TTM) | -1.69 | 2.13 |
| P/S Ratio (TTM) | 0.34 | 1.68 |
| P/B Ratio (TTM) | 1.18 | 3.09 |
| P/FCF Ratio (TTM) | 4.17 | 11.15 |
| Price to 5YR AVG Earnings Ratio | -57.82 | 1.24 |
| Price to 5YR AVG FCF Ratio | 8.22 | 32.92 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.64% | 7.52% |
| ROE (TTM) | 11.37% | 17.66% |
| Net Profit Margin (TTM) | 3.09% | 9.27% |
| ROIC 5YR AVG | 6.48% | 6.25% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.69% | -649.23% | -327.46% |
| Revenue | -2.39% | -12.73% | -2.12% |
| Net Income | 1.26% | -254.70% | -83.96% |
| Cash Flow | 12.03% | 743.10% | 619.72% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.99 | 1.84 |
| Quick Ratio (TTM) | 1.11 | 1.32 |
| D/E Ratio (TTM) | 0.13 | 1.10 |
| Interest Coverage (TTM) | 6.00 | 16.52 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 2.73 | 2.92 |
| LTL to 5YR AVG FCF | 1.49 | 7.96 |
| Shares Outstanding Growth 5YR AVG | -1.29% | 6.67% |